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equally apply to management of perfusion pressure during 
cardiac operations as well. 
Arthur S. Keats, MD 
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Texas Heart Institute 
Houston, TX 77225-0345 
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Reply to the Editor." 
The members of the Cornell Coronary Artery Bypass 
Outcomes Trial Group (CCABOT) thank Drs. Keats and 
Slogoff for their insightful comments and appreciate the 
opportunity to expand on the points that they have raised 
in their letter regarding our article, a The trial was de- 
signed as a prospective randomized study at the outset. 
The criteria for major and minor outcomes were set a 
priori. The principal outcomes were as follows: all cause 
mortality, cardiopulmonary morbidity (myocardial infarc- 
tion, pulmonary edema, adult respiratory distress syn- 
drome, cardiogenic shock/low flow state, and cardiopul- 
monary arrest), neurologic morbidity (new major focal 
deficit), cognitive complications (defined by intrapatient 
deterioration on neurocognitive t sts), and deterioration 
in functional status (decline on the SF-36 health survey). 
Minor outcomes were also determined a priori and were 
not included as principal outcomes. The minor cardiac 
outcomes included myocardial ischemia and congestive 
heart failure and the minor neurologic outcomes included 
focal deficit lasting less than 24 hours. All major and 
minor outcomes were counted up to the 6-month interval 
after the operation and were stipulated before the start of 
the trial. 
When the major outcomes were analyzed at the com- 
pletion of the trial, it was found that patients randomized 
to the low mean arterial pressure (MAP) group had a 
higher incidence of all cause death, major cardiac ompli- 
cations, and major neurologic omplications. The com- 
bined incidence of total mortality and major cardiac and 
neurologic morbidity was 12.9% in the low MAP group 
versus 4.8% in the high MAP group (p = 0.026). The 
incidence of deterioration i neurocognitive function and 
deterioration i  functional status did not differ between 
the two groups. 
The mean arterial pressures between the low and high 
MAP groups differed by an average of 18 mm Hg. As 
shown in Table VI (the pragmatic analysis), which dem- 
onstrates the actual pressure achieved regardless of ran- 
domization group, the trend toward lower complications 
with higher pressures can clearly be seen. 
Although it is tempting to ascribe differences in out- 
come to variables other than the therapeutic maneuver, 
which was assigned by randomization, it is extremely 
unlikely that the pattern of specific variables differed 
appreciably between the two MAP groups. The very 
raison d'6tre of a randomized trial is the statistical balance 
of potential confounding factors, both those previously 
identified and those unknown at the inception of the trial. 
Table I of the article demonstrates this balance for a large 
number of such variables. Furthermore, although not 
incorporated into the paper, many additional factors were 
analyzed to ascertain whether there were any differences 
between the two MAP groups, either before or after 
bypass. All of these items, including MAPs, cardiac out- 
puts, anesthetic agents, vasoactive medications, other 
medications, blood gases, activated clotting times, hemat- 
ocrit values, and other hemodynamic parameters were not 
found to differ between the two treatment groups. 
Pilot subsets of patients enrolled in the present trial also 
underwent preoperative transesophageal chocardiogram 
and intraoperative transcranial Doppler ultrasonography; 
because these subsets were selected after randomization 
and were examined in a nonrandom fashion, they cannot 
yield unbiased information on the importance of athero- 
matous disease or embolic load for the entire 248-patient 
cohort randomized to two treatment arms. Because ath- 
eromatous disease of the aorta is now thought o be a risk 
factor for perioperative complications of coronary by- 
pass, 2the reproducible quantification of aortic atheroma 
by transesophageal echocardiography is under develop- 
ment. 3Future clinical trials of coronary bypass will incor- 
porate these procedures in all patients. 
Animal and human data support the conclusion that 
autoregulation f cerebral blood flow occurs across the range 
of MAPs of 50 to 150 mm Hg. As observed, 54 mm Hg falls 
within this range. However, the data also suggest that the 
autoregulatory range of cerebral blood flow is shifted to the 
right in patients with longstanding hypertension. In addition, 
these conclusions are based on experiments inwhich global 
cerebral blood flow was measured uring the conditions of 
normothermic pulsatile peffusion. Extension of these con- 
clusions to the conditions of nonpulsatile, hypothermic by- 
pass with attention to regional blood flow may not be valid. 
Patients with coronary artery disease are known to have an 
increased incidence of other vascular disease, including that 
of the cerebral circulation. Higher perfusion pressures may 
permit the maintenance of adequate blood flow to areas 
distal to stenotic vessels or facilitate recruitment ofcollateral 
blood flow, thus minimizing the affected area of ischemia. 
Jeffrey P. Gold, MD 
Department of Cardiothoracic Surgery 
The New York Hospital Cornell Medical Center 
New York, NY 10021 
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Mitral valve repair 
To the Editor." 
My colleagues and I read with interest he article by 
Hvass and associates (J Thorac Cardiovasc Surg 1995;110: 
859-62), in which they described a technique for mitral 
valve repair that closely resembled a procedure we de- 
scribed in this Journal in 1994 (1994;107:635-8). We both 
described a technique of grafting the posterior leaflet of 
the tricuspid valve, with the chordae tendineae and pap- 
illary muscle, to the rnitral valve l aflets for the correction 
of mitral valve insufficiency. 
To our surprise, the authors made no reference to our 
work in their article. Inasmuch as our letter was published 
in the same Journal, we thought that it could not have 
escaped the attention of either the authors or the referees. 
We would also like to draw attention to the fact that we 
suggested further use of this technique for partial replace- 
ment of the leaflets in the case of localized calcification of 
the mitral valve. 
We are glad that Dr. Hvass and his group have con- 
firmed the efficiency of this technique, which we have now 
used successfully in 20 cases. 
Francisco Gregori, Jr., MD 
Professor of Cardiac Surgery 
State University of Londrina 
School of Medicine 
Londrina, Parand, Brazil 
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A simple switching technique from 
cardiopulmonary bypass to a long-term 
extracorporeal ife support system 
To the Editor: 
We read with great interest the article by Muehrcke and 
associates 1 in the September 1995 issue of the Journal. ~ 
They summarized their clinical experiences with an extra- 
corporeal life support (ECLS) system and reported that 
limb ischemia was the most common complication, found 
in 70% of patients who underwent percutaneous ECLS. 
Besides limb ischemia, bleeding from the surgical wound 
is also a life-threatening complication of ECLS. 1' 2 Since 
1965 we have used ECLS in more than 60 patients with 
severe cardiopulmonary failure. 3'4 To overcome the 
aforementioned problems, we recently began routinely 
using the following technique (Fig. 1). 
~ 4 
Fig. 1. A cannulation technique to switch from CPB to 
ECLS for postcardiotomy cardiac failure. A Dacron vas- 
cular graft is sutured to the right femoral artery. A 12F 
wire-reinforced cannula is inserted through the saphenous 
vein to the distal femoral vein. A 21F heparin-bonded 
cannula is inserted through the femoral vein to the right 
atrium. The lines are connected to a heparin-bonded 
ECLS system. The CPB flow is decreased and the ECLS 
flow is increased to allow the switch. A, artery; V, vein. 
When a patient is difficult to wean from cardiopulmo- 
nary bypass (CPB) because of cardiac failure, an intraaor- 
tic balloon pump is initially inserted in the left femoral 
artery after an 8 mm sealed Dacron prosthesis has been 
sutured to the left femoral artery in an end-to-side 
fashion. The intraaortic balloon pump is started in a 1:1 
mode. The ECLS is set up during CPB. The entire system 
is heparin-bonded and composed of a capillary membrane 
oxygenator (Maxima: CB1380, Medtronic Inc., Cardiopul- 
monary Div., Anaheim, Calif.), a Bio-Medieus model 
540T centrifugal pump (Medtronic Bio-Medicus, Eden 
Prairie, Minn.), and tubes and connectors. Our switching 
procedure is illustrated in Fig. 1. The right femoral artery 
and vein are taped. A second 8 mm sealed Dacron 
prosthesis i  sutured to the femoral artery in an end-to- 
side fashion and then connected to the arterial line of the 
ECLS system. A 12F wire-reinforced cannula is inserted 
through the saphenous vein to the distal femoral vein and 
fixed with 3-0 silk. The CPB flow is decreased 50% and the 
inferior vena caval cannula used for CPB is removed. A
21F heparin-bonded wire-reinforced cannula with multi- 
ple side holes (Medtronic) is inserted through the femoral 
vein to the right atrium and fixed with two Teflon tapes 
with double ligation. The two venous cannulas are con- 
